1-4 of 4
Sarah Horowitz
Close
Sort by
Journal Articles

Alemtuzumab-Containing Allogeneic Hematopoietic Cell Transplant (HCT) for Relapsed Lymphomas: Prognostic Factors and Outcome.

Vaishalee P. Kenkre, MD, Sarah Horowitz, Sonali M. Smith, MD, Andrew Artz, MD, MS, Kenneth S. Cohen, MD, Lucy A Godley, M.D., Ph.D., Justin Kline, M.D., Wendy Stock, MD, Koen van Besien, MD
Journal: Blood
Blood (2009) 114 (22): 2247.
https://doi.org/10.1182/blood.V114.22.2247.2247
Published: 2009
Journal Articles

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab (CMA) Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Determination of MTD and Outcomes.

Koen van Besien, MD, Justin Kline, Lucy A Godley, MD, PhD, Richard A. Larson, MD, Vu H. Nguyen, MD, Olatoyosi Odenike, MD, Elizabeth Shima Rich, MD, PhD, Wendy Stock, MD, Amittha Wickrema, PhD, Scott Allen, BA, Paula del Cerro, Sarah Horowitz, Lisa Pape, RN, Linda Schroeder, RN, Andrew Artz, MD, MS
Journal: Blood
Blood (2009) 114 (22): 197.
https://doi.org/10.1182/blood.V114.22.197.197
Published: 2009
Journal Articles

Allogeneic Hematopoietic Cell Transplantation From Combined Haploidentical Family Members and Unrelated Cord Blood (CB) Can Benefit High Risk Patients Lacking HLA-Identical Donors.

Elizabeth Shima Rich, MD, PhD, Andrew Artz, MD, MS, Theodore Karrison, Ph.D., Lucy A Godley, MD, PhD, Olatoyosi Odenike, MD, Loren Joseph, MD, Justin Kline, MD, Vu H. Nguyen, MD, Guadalupe Martinez, BS, Paula del Cerro, RN, Lisa Pape, RN, Linda Schroeder, RN, Scott Allen, BA, Sarah Horowitz, BA, John Cunningham, MD, Richard A. Larson, MD, Wendy Stock, MD, Amittha Wickrema, PhD, Koen van Besien, MD
Journal: Blood
Blood (2009) 114 (22): 3378.
https://doi.org/10.1182/blood.V114.22.3378.3378
Published: 2009
Journal Articles

Remission Status and Performance Status, but Not Cytogenetic Risk Group, Are Associated with Outcome After Reduced Intensity Conditioning (RIC) and Allogeneic Hematopoietic Cell Transplantation (HCT) for Therapy-Related Myeloid Neoplasms (t-MN): Results of the University of Chicago Experience.

Vaishalee P. Kenkre, MD, Sarah Horowitz, Richard A. Larson, MD, Andrew Artz, MD, MS, Elizabeth Shima Rich, MD, PhD, Yanming Zhang, M.D., M.S., Michelle M. Le Beau, PhD, Lucy A Godley, MD, PhD, Olatoyosi Odenike, MD, Michael Thirman, MD, Koen van Besien, MD, Wendy Stock, MD
Journal: Blood
Blood (2009) 114 (22): 3395.
https://doi.org/10.1182/blood.V114.22.3395.3395
Published: 2009